Effect of sustained release terbutaline on symptoms and sleep quality in patients with nocturnal asthma.
The effect of an oral sustained release beta 2 agonist on symptoms, sleep quality, and peak flow rates has been studied in nine patients with nocturnal asthma. Patients received oral terbutaline 7.5 mg twice daily or placebo for seven days in a double blind crossover study and spent the last two nig...
שמור ב:
| הוצא לאור ב: | Thorax |
|---|---|
| Principais autores: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BMJ Publishing Group
1987
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC460955/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3321540/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/thx.42.10.797 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|